Previous studies have identified that Fusobacterium nucleatum (Fn), the most prevalent bacterial species in CRC, can adhere to the surface of tumor cells by specifically targeting the inhibitory receptor TIGIT, to inhibit immune cell activities [16]. The gene discussed is FN1; the disease is colorectal carcinoma.